Home›Companies›Healthcare›Paradromics

Paradromics, Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 7, 2023·Suggest an edit

About Paradromics

Paradromics is a private company based in Austin, Texas. It has reported $96,886,744 raised in seven offerings on Form D since March 2016. Its chief executive is Matthew Angle.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 21, 2023Apr 5, 2023amended Nov 7, 2023$50,141,276of $51.0M target53$946KEquityRule 506(b)Form D/A ↗1 earlier filing
Feb 17, 2022Sep 21, 2022$8,864,853fully sold9$984KEquity, DebtRule 506(b)Form D ↗
Jan 15, 2021Feb 1, 2021amended Oct 19, 2021$28,230,600fully sold42$672KEquityRule 506(b)Form D/A ↗2 earlier filings
Mar 29, 2019Apr 15, 2019$1,350,000of $3.0M target6$225KDebt, OptionsRule 506(b)Form D ↗
Feb 27, 2018Mar 14, 2018amended May 22, 2018$7,140,015fully sold34$210KEquityRule 506(b)Form D/A ↗1 earlier filing
May 24, 2017Jun 5, 2017$175,000of $1.0M target2$87,500Debt, Options, Securities on exerciseRule 506(b)Form D ↗
Aug 3, 2015Mar 1, 2016$985,000of $1.2M target16$61,563Debt, Options, Securities on exerciseRule 506(b)Form D ↗
Total, seven offerings$96,886,744

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Paradromics's Form D filed Nov 7, 2023.

HE
Helmy Eltoukhy
Executive officer and director
MA
Matthew Angle
CEO and director
AK
Amy Kruse
Director
Also a prime movers lab and director at Cognixion and a director at Gilgamesh Pharma and Morphoceuticals.

Earlier filings also listed James Burrows (executive officer and director, last listed Sep 2022), Adam Kablanian (director, last listed Sep 2022), Yifan Kong (director, last listed Apr 2019), Enke Bashllari (director, last listed Apr 2019), Edmund Huber (director, last listed Apr 2019), Thomas Krummel (director, last listed May 2018) and Ron Kelly (director, last listed May 2018).

Sources

  1. SECParadromics, Inc. Form D, filed Apr 5, 2023
  2. SECParadromics, Inc. Form D/A, filed Jul 23, 2021
  3. SECParadromics, Inc. Form D, filed Feb 1, 2021
  4. SECParadromics, Inc. Form D, filed Mar 14, 2018
  5. SECParadromics, Inc. filing history